A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia

Clinical trial NCT01124617 · COMPLETED

Trial details

NCT number: NCT01124617
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pain Diabetic Neuropathies Neuralgia Postherpetic Neuralgia

Start date: 2010-06-01
Primary completion: 2011-04-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.